MyAverix Finance
NS · Pharmaceuticals
Gufic Biosciences Ltd (GUFICBIO)
Pharmaceuticals & Biotechnology
Gufic Biosciences Ltd (GUFICBIO) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-04, reported market cap is $37.10B, P/E ratio is 58.73, net margin is 8.6%, dividend yield is 0.03%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for GUFICBIO
Gufic Biosciences Ltd (GUFICBIO) — FAQ
What is Gufic Biosciences Ltd's market cap?
Gufic Biosciences Ltd (GUFICBIO) has a reported market cap of $37.10B (data as of 2026-07-04).
What is GUFICBIO's P/E ratio?
The price-to-earnings (P/E) ratio for Gufic Biosciences Ltd (GUFICBIO) is 58.73 (data as of 2026-07-04).
Does Gufic Biosciences Ltd pay a dividend?
Gufic Biosciences Ltd (GUFICBIO) shows a reported dividend yield of 0.03%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-04).
What sector is Gufic Biosciences Ltd in?
Gufic Biosciences Ltd (GUFICBIO) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is GUFICBIO listed on?
GUFICBIO is listed on NS.
What is Gufic Biosciences Ltd's net margin?
Gufic Biosciences Ltd (GUFICBIO) reports a net margin of 8.6% (data as of 2026-07-04).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.